Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hologic Produces the First FDA-Approved 3D Mammography Platform
Yahoo/GuruFocus
Wednesday, November 26, 2014 - 4:48pm
tags:
Hologic, FDA, 3-D mammograms, devices
Will Insulin Pricing Be MannKind Corporation's Downfall?
Motley Fool
Wednesday, November 26, 2014 - 12:11pm
tags:
MannKind, diabetes, insulin, inhaled insulin, Afrezza, drug pricing
FDA declines to approve Bristol-Myers hepatitis drug
Yahoo/Reuters
Wednesday, November 26, 2014 - 12:08pm
tags:
hepatitis C, Bristol-Myers Squibb, FDA, daclatasvir
Vivus awarded two patents for Qsymia
Seeking Alpha
Wednesday, November 26, 2014 - 12:05pm
tags:
Vivus, Qsymia, patents
Valeant adds to dermatology portfolio
Medical Marketing and Media
Wednesday, November 26, 2014 - 12:02pm
tags:
dermatology, Valeant Pharmaceuticals, FDA, Onexton, acne
Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push
Fierce Pharma Marketing
Wednesday, November 26, 2014 - 11:50am
tags:
Ipsen, Somatuline, hirings, drug launches
Who are the stars of personalized medicine? Roche, Novartis and J&J
Fierce Pharma Marketing
Wednesday, November 26, 2014 - 11:43am
tags:
personalized medicine, Roche, Novartis, JNJ
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wednesday, November 26, 2014 - 11:38am
tags:
Amgen, AstraZeneca, brodalumab, JNJ, Stelara, psoriasis
Ackman's Pershing Square still holds 26.6 million Allergan shares
Yahoo/Reuters
Wednesday, November 26, 2014 - 11:35am
tags:
Bill Ackman, Allergan, M&A, Valeant Pharmaceuticals, Actavis
Should Drug Makers be Required to Take FDA Advice on Pivotal Trials?
WSJ Pharmalot
Wednesday, November 26, 2014 - 11:32am
tags:
FDA, clinical trials
Back for more: Will Pfizer top its AstraZeneca bid?
CNBC
Wednesday, November 26, 2014 - 10:07am
tags:
Pfizer, AstraZeneca, M&A
J&J hopes third time is the charm for antitumor agent Yondelis
Fierce Biotech
Tuesday, November 25, 2014 - 3:53pm
tags:
JNJ, Yondelis, ovarian cancer
Once-weekly Lilly diabetes drug wins EU approval
Yahoo/Reuters
Tuesday, November 25, 2014 - 3:19pm
tags:
Eli Lilly, diabetes, Europe, Trulicity
Covidien, Medtronic Shareholders Poised for January Vote
Yahoo/TheStreet
Tuesday, November 25, 2014 - 1:46pm
tags:
Covidien, Medtronic, M&A, devices
Ousted Retrophin CEO Sold Stock While Urging Investors to Buy
TheStreet.com
Tuesday, November 25, 2014 - 1:40pm
tags:
Retrophin, Martin Shkreli
Glaxo Said to Sell 2.5 Billion Euros of Bonds as Rates Fall
Bloomberg
Tuesday, November 25, 2014 - 1:36pm
tags:
GSK, bonds
Biogen’s Tecfidera Label Updated After Rare Brain Infection Case
Bloomberg
Tuesday, November 25, 2014 - 1:35pm
tags:
Biogen Idec, Tecfidera, PML
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN)
TheStreet.com
Tuesday, November 25, 2014 - 1:33pm
tags:
Seattle Genetics
What are the odds? Pfizer-AstraZeneca merger chatter heats up
Fierce Biotech
Tuesday, November 25, 2014 - 11:09am
tags:
Pfizer, AstraZeneca, M&A
JNJ, Transposagen To Co-Develop CAR-T Therapy
Bidness Etc.
Tuesday, November 25, 2014 - 11:04am
tags:
JNJ, Transposagen, CAR-T, cancer immunotherapy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.